Literature DB >> 18344952

Heavy tamponade 1: a review of indications, use, and complications.

H Heimann1, T Stappler, D Wong.   

Abstract

BACKGROUND: Heavier than water intraocular tamponades have several theoretical advantages over conventional tamponades, especially in the treatment of complicated retinal detachments and proliferative viteroretinopathy of the lower fundus periphery. However, initial clinical series of various heavy tamponades have reported significant complication rates. Therefore, heavy tamponades have not found widespread acceptance. Three recently developed heavy silicone oil tamponades, Oxane HD, Densiron 68, and HWS 46-3000, are much better tolerated and presently seem to enter routine clinical practice.
MATERIALS AND METHODS: Literature review of 21 publications on the clinical application of 9 different heavy tamponades (fluorosilicone, C10F18, F6H8, OL62HV, Oxane HD, O62, F6H8-silicone oil mixture, Densiron 68, and HWS 46-3000).
RESULTS: The first generation (fluorinated silicone and perfluorocarbon liquids) and second generation (partially fluorinated alkanes) of heavy tamponades were associated with relatively high complication rates, for example, tamponade emulsification, intraocular inflammation, and rise in intraocular pressure. The complication spectrum of the new generation of heavy silicone oils (Oxane HD, Densiron 68, and HWS 46-3000) seems to be comparable to conventional silicone oil tamponades while providing better support for the inferior retina and the posterior pole.
CONCLUSION: The recently developed heavy silicone oil tamponades are safe and effective tools for the use of complicated retinal detachments of the inferior fundus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18344952     DOI: 10.1038/eye.2008.61

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  33 in total

1.  [Glaucoma and retinal surgery].

Authors:  M Müller; G Geerling; M Zierhut; T Klink
Journal:  Ophthalmologe       Date:  2010-05       Impact factor: 1.059

2.  Dynamics of the macular hole-silicone oil tamponade interface with patient positioning as imaged by spectral domain-optical coherence tomography.

Authors:  Stephen F Oster; Francesca Mojana; Dirk-Uwe G Bartsch; Michael Goldbaum; William R Freeman
Journal:  Retina       Date:  2010-06       Impact factor: 4.256

3.  Primary vitrectomy with Densiron-68 for rhegmatogenous retinal detachment.

Authors:  M R Romano; T Stappler; J Marticorena; C Groenewald; I Pearce; S K Gibran; D Wong; H Heimann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-07-11       Impact factor: 3.117

4.  Intravitreal silicone oil induced changes in corneal biomechanics.

Authors:  Mehmet Y Teke; Ufuk Elgin; Emine Sen; Pinar Ozdal; Faruk Ozturk
Journal:  Int Ophthalmol       Date:  2013-07-16       Impact factor: 2.031

5.  The use of silicone oil-RMN3 (Oxane HD) as heavier-than-water internal tamponade in complicated inferior retinal detachment surgery.

Authors:  Louisa Wickham; Paris Tranos; Paul Hiscott; David Charteris
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-03-27       Impact factor: 3.117

6.  Long-term heavy silicone oil intraocular tamponade.

Authors:  Ian J Dooley; Emma S Duignan; Dara J Kilmartin
Journal:  Int Ophthalmol       Date:  2015-03-27       Impact factor: 2.031

7.  Anatomical and functional outcomes after Densiron 68 heavy silicone oil tamponade for complicated retinal detachment in Chinese eyes.

Authors:  Fang Liu; Hui Li; Le Feng; Fang Wang
Journal:  Int J Ophthalmol       Date:  2014-06-18       Impact factor: 1.779

Review 8.  [Toxicity of heavy liquids].

Authors:  Kai Januschowski; Peter Szurman; Koen Willekens; Michael J Bojdys; Karl Boden
Journal:  Ophthalmologe       Date:  2019-10       Impact factor: 1.059

9.  Intraocular pressure changes following the use of silicone oil or Densiron 68 as endotamponade in pars plana vitrectomy.

Authors:  Mario R Romano; Martina Angi; Vito Romano; Francesco Parmeggiani; Claudio Campa; Xavier Valldeperas; Ciro Costagliola
Journal:  Clin Ophthalmol       Date:  2010-11-26

10.  A cross-linked hyaluronic acid hydrogel (Healaflow(®)) as a novel vitreous substitute.

Authors:  Henrik Barth; Sven Crafoord; Sten Andréasson; Fredrik Ghosh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-01-08       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.